glutathione s-transferase antioxidant Frontiers Glutathione-S-Transferases as Potential Targets for
Description
It is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered
(1994) Changes in plasma glutathione concentrations, turnover, and disposal in developing rats
Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier
The latter increases with increasing purulence owing to the presence of cellular debris
